The pivotal role of dysregulated autophagy in the progression of non-alcoholic fatty liver disease
Open accessThe DOI matches its Crossref record; 196 of the 197 references it cites were found in a registry or an index.
Abstract
Non-alcoholic fatty liver disease (NAFLD) is a clinicopathologic syndrome characterized by excessive fat deposition in hepatocytes and a major cause of end-stage liver disease. Autophagy is a metabolic pathway responsible for degrading cytoplasmic products and damaged organelles, playing a pivotal role in maintaining the homeostasis and functionality of hepatocytes. Recent studies have shown that pharmacological intervention to activate or restore autophagy provides benefits for liver function recovery by promoting the clearance of lipid droplets (LDs) in hepatocytes, decreasing the production of pro-inflammatory factors, and inhibiting activated hepatic stellate cells (HSCs), thus improving liver fibrosis and slowing down the progression of NAFLD. This article summarizes the physiological process of autophagy, elucidates the close relationship between NAFLD and autophagy, and discusses the effects of drugs on autophagy and signaling pathways from the perspectives of hepatocytes, kupffer cells (KCs), and HSCs to provide assistance in the clinical management of NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, several antifibrotic interventions -including traditional Chinese medicinal (TCM) compounds and pharmaceutical agents such as metformin, glucagon-like peptide-1 receptor agonists (GLP-1RAs) or SGLT2 inhibitors (SGLT2is)- promote restorative macrophage polarization, at least in part, through activation of AMPK-dependent pathways and enhance hepatic autophagy (34, 39, 41–44).”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Its induction promotes a shift toward a restorative macrophage phenotype, whereas proinflammatory stimuli such as LPS suppress autophagic flux and favor pro-fibrotic polarization (34, 38–40).”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [39]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,306
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418 · cited 1×
“Finally, autophagosomes form autolysosomes by transporting their cargo into lysosomes and fusing with them (44).”
BackgroundAutophagy regulates lipid metabolism
Singh, R., Kaushik, S., Wang, Y., Xiang, Y., Novak, I., Komatsu, M., Tanaka, K., Cuervo, A. M., & Czaja, M. J. (2009) · Nature · doi:10.1038/nature07976 · Cited by 3,975 · cited 1×
“Hepatocyte autophagy can enhance lipophagy, selectively degrade LDs, and thus improve lipid metabolism in NAFLD (96, 97).”
BackgroundMAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
Eslam, M., Sanyal, A. J., George, J., Sanyal, A., Neuschwander-Tetri, B., Tiribelli, C., Kleiner, D. E., Brunt, E., Bugianesi, E., Yki-Järvinen, H., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.312 · Cited by 3,286 · cited 1×
“NAFLD is a metabolic disease involving abnormal liver fat metabolism, which has recently been renamed as metabolism-associated fatty liver disease (MAFLD) (3), as represented by NAFLD in the following article.”
BackgroundMechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909 · cited 1×
“However, activation of HSCs enhances extracellular matrix (ECM) production, which is a key initiating event in hepatic fi brosis and plays a crucial role in NAFLD progression (109, 110).”
BackgroundHepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842 · cited 1×
“HSCs, situated in the Disse space between the lateral basal region of hepatocytes and the surface of sinusoidal endothelial cells, serve as the principal producers of collagen within the liver (107).”
BackgroundBiological Functions of Autophagy Genes: A Disease Perspective
Levine, B., & Kroemer, G. (2019) · Cell · doi:10.1016/j.cell.2018.09.048 · Cited by 2,832 · cited 1×
“These ATG proteins, in conjunction with autophagy regulatory factors, play a crucial role in regulating the autophagic process (26, 27).”
BackgroundMechanism and medical implications of mammalian autophagy
Dikic, I., & Elazar, Z. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0003-4 · Cited by 2,771 · cited 3×
“Signi fi cantly, autophagosomes and autolysosomes are two essential components in the formation of autophagy (17).”
BackgroundAn Overview of Autophagy: Morphology, Mechanism, and Regulation
Parzych, K. R., & Klionsky, D. J. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5371 · Cited by 2,521 · cited 4×
“Three types of autophagy have been identi fi ed, namely microautophagy, macroautophagy, and CMA.”
BackgroundInfluentialFrom endoplasmic-reticulum stress to the inflammatory response
Zhang, K., & Kaufman, R. J. (2008) · Nature · doi:10.1038/nature07203 · Cited by 2,010
Shaw, R. J., Kosmatka, M., Bardeesy, N., Hurley, R. L., Witters, L. A., DePinho, R. A., & Cantley, L. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308061100 · Cited by 1,797
Autophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585 · cited 2×
“Defects in autophagy are implicated in the pathogenesis of numerous diseases, including tumors, neurodegenerative disorders, and metabolic conditions (16).”
BackgroundRole of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks
Alers, S., Löffler, A. S., Wesselborg, S., & Stork, B. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06159-11 · Cited by 1,483
The coming of age of chaperone-mediated autophagy
Kaushik, S., & Cuervo, A. M. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0001-6 · Cited by 1,407 · cited 1×
“CMA is a highly selective form of autophagy that often involves binding to the molecular chaperone heat-shock cognate protein in order to transport substrate proteins to the lysosomal surface for internalization and rapid degradation within the lysosomal lumen (24).”
BackgroundMacrophages: master regulators of inflammation and fibrosis
Wynn, T., & Barron, L. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1255354 · Cited by 1,392 · cited 1×
“KCs, the liver-resident macrophages, originate from yolk sac progenitor cells and are integral to liver homeostasis, in fl ammation, and fi brosis regulation (98, 99).”
BackgroundNix is a selective autophagy receptor for mitochondrial clearance
Novak, I., Kirkin, V., McEwan, D. G., Zhang, J., Wild, P., Rozenknop, A., Rogov, V., Löhr, F., Popovic, D., Occhipinti, A., et al. (2010) · The EMBO Reports · doi:10.1038/embor.2009.256 · Cited by 1,309
Nakatogawa, H., Ichimura, Y., & Ohsumi, Y. (2007) · Cell · doi:10.1016/j.cell.2007.05.021 · Cited by 1,209
Cargo recognition and degradation by selective autophagy
Gatica, D., Lahiri, V., & Klionsky, D. J. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0037-z · Cited by 1,067 · cited 2×
“However, selective autophagy is a cellular response mechanism that speci fi cally targets cargoes for degradation in lysosomes upon exposure of cells to various stresses, such as DNA damage (52, 53).”
BackgroundKoliaki, C., Szendroedi, J., Kaul, K., Jelenik, T., Nowotny, P., Jankowiak, F., Herder, C., Carstensen, M., Krausch, M., Knoefel, W. T., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.004 · Cited by 1,032 · cited 2×
“As a result, this activation triggers KCs and accelerates the progression of NAFLD (94).”
BackgroundTFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop
Settembre, C., De Cegli, R., Mansueto, G., Saha, P. K., Vetrini, F., Visvikis, O., Huynh, T., Carissimo, A., Palmer, D., Jürgen Klisch, T., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2718 · Cited by 1,022 · cited 1×
“The regulation of TFEB can enhance lysosome biosynthesis, autophagosome formation, and their fusion with lysosomes and promote autophagy fl ux, a crucial regulatory factor in lipolysis (64).”
BackgroundThe mechanisms and roles of selective autophagy in mammals
Vargas, J. N. S., Hamasaki, M., Kawabata, T., Youle, R. J., & Yoshimori, T. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00542-2 · Cited by 1,016
Autophagy—a key player in cellular and body metabolism
Kim, K. H., & Lee, M.-S. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.35 · Cited by 963 · cited 1×
“Autophagy is governed by a complex series of regulatory mechanisms, including initiation, formation of autophagosomes, formation of autolysosomes, degradation, and termination of recycling (25).”
BackgroundRegulation of endoplasmic reticulum turnover by selective autophagy
Khaminets, A., Heinrich, T., Mari, M., Grumati, P., Huebner, A. K., Akutsu, M., Liebmann, L., Stolz, A., Nietzsche, S., Koch, N., et al. (2015) · Nature · doi:10.1038/nature14498 · Cited by 956 · cited 1×
“Under ERS induction, the disruption of the ER structure is recognized by the ER receptor and leads to binding with LC3/GABARAP/ATG8, thereby promoting ER autophagy (79).”
BackgroundEndoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease
Lebeaupin, C., Vallée, D., Hazari, Y., Hetz, C., Chevet, E., & Bailly-Maitre, B. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.06.008 · Cited by 944
Hepatic lipocytes: the principal collagen-producing cells of normal rat liver.
Friedman, S. L., Roll, F. J., Boyles, J., & Bissell, D. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8681 · Cited by 859 · cited 1×
“In healthy livers, quiescent HSCs facilitate the intercellular transport of cytokines and soluble mediators (108).”
BackgroundLipotoxicity and the gut-liver axis in NASH pathogenesis
Marra, F., & Svegliati-Baroni, G. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.014 · Cited by 847 · cited 1×
“However, lipotoxicity induces mitochondrial dysfunction, triggering endoplasmic reticulum stress (ERS) and lipid peroxidation (10).”
BackgroundAMPK and mTOR in Cellular Energy Homeostasis and Drug Targets
Inoki, K., Kim, J., & Guan, K.-L. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134537 · Cited by 791 · cited 1×
“Moreover, the AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) are two pivotal components involved in the regulation of autophagy (28).”
BackgroundAutophagy in the Cellular Energetic Balance
Singh, R., & Cuervo, A. M. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.04.004 · Cited by 788 · cited 2×
“In a state of starvation, autophagy degrades LDs in hepatocytes to release fatty acids to the mitochondria for b - oxidation, thereby regulating lipid storage and energy balance in hepatocytes (55).”
Backgroundp62/SQSTM 1 functions as a signaling hub and an autophagy adaptor
Katsuragi, Y., Ichimura, Y., & Komatsu, M. (2015) · The FEBS Journal · doi:10.1111/febs.13540 · Cited by 788 · cited 2×
“…P62/ sequestosome1 (SQSTM1) functions as an autophagy adaptor protein that mediates the interaction between ubiquitin-like proteins and LC3II, facilitating expansion of phagocytic cells and promoting closure of the isolation membrane to facilitate formation of autophagosomes (43) (Figure 1).”
BackgroundHanna, R. A., Quinsay, M. N., Orogo, A. M., Giang, K., Rikka, S., & Gustafsson, Å. B. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.322933 · Cited by 762
Kaushik, S., & Cuervo, A. M. (2015) · Nature Cell Biology · doi:10.1038/ncb3166 · Cited by 714 · cited 1×
“During the process of The biological process of autophagy. lipophagy, lipid droplet-associated proteins perilipin 2 (PLIN2) and perilipin 3 (PLIN3) are degraded through CMA by a synergistic effect of Hsc70 and lysosome-associated membrane protein 2A (LAMP-2A) receptors (62).”
BackgroundWisse, E., de Zanger, R. B., Charels, K., van der Smissen, P., & McCuskey, R. S. (1985) · Hepatology · doi:10.1002/hep.1840050427 · Cited by 712
Wen, Y., Lambrecht, J., Ju, C., & Tacke, F. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00558-8 · Cited by 695
Cellular mitophagy: Mechanism, roles in diseases and small molecule pharmacological regulation
Lu, Y., Li, Z., Zhang, S., Zhang, T., Liu, Y., & Zhang, L. (2023) · Theranostics · doi:10.7150/thno.79876 · Cited by 685 · cited 1×
“Parkin ubiquitinates outer membrane proteins and recruits P62 to damaged mitochondria, resulting in changes in autophagosome membrane structure and initiating selective mitophagy (69, 70).”
BackgroundMechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis
Schwabe, R. F., Tabas, I., & Pajvani, U. B. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.311 · Cited by 671
Machinery, regulation and pathophysiological implications of autophagosome maturation
Zhao, Y. G., Codogno, P., & Zhang, H. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00392-4 · Cited by 572 · cited 1×
“Meanwhile, the PtdIns3P protein on autophagosomes facilitates fusion with lysosomes by recruiting the HOPS complex tethering factor (48, 49).”
BackgroundCytosolic lipolysis and lipophagy: two sides of the same coin
Zechner, R., Madeo, F., & Kratky, D. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.76 · Cited by 550 · cited 4×
“Thus, adipose triglyceride lipase (ATGL) is a cytosolic lipase involved in lipolysis, which releases free fatty acids (FFAs) that can serve as substrates for mitochondrial b -oxidation or as potent signaling molecules for various cellular processes (60).”
BackgroundInfluentialDeter, R. L., & de Duve, C. (1967) · The Journal of Cell Biology · doi:10.1083/jcb.33.2.437 · Cited by 538
A Diversity of Selective Autophagy Receptors Determines the Specificity of the Autophagy Pathway
Kirkin, V., & Rogov, V. V. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.09.005 · Cited by 529
Endoplasmic reticulum stress, the unfolded protein response and autophagy in kidney diseases
Cybulsky, A. V. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.129 · Cited by 526 · cited 1×
“Additionally, the PERK pathway induces autophagy by suppressing mTORC1 activity (82, 83).”
BackgroundMelatonin and endoplasmic reticulum stress: relation to autophagy and apoptosis
Fernández, A., Ordóñez, R., Reiter, R. J., González‐Gallego, J., & Mauriz, J. L. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12264 · Cited by 515
Selective autophagy of intracellular organelles: Recent research advances
Li, W., He, P., Huang, Y., Li, Y.-F., Lu, J., Li, M., Kurihara, H., Luo, Z., Meng, T., Onishi, M., et al. (2021) · Theranostics · doi:10.7150/thno.49860 · Cited by 507
Lysosome biogenesis: Regulation and functions
Yang, C., & Wang, X. (2021) · Journal of Cell Biology · doi:10.1083/jcb.202102001 · Cited by 473 · cited 2×
“Ultimately, lysosomal proteases release degraded products into extracellular environment to promote recycling of these materials (51) (Figure 1).”
BackgroundThe emerging mechanisms and functions of microautophagy
Wang, L., Klionsky, D. J., & Shen, H.-M. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00529-z · Cited by 466
TFEB and TFE3: Linking Lysosomes to Cellular Adaptation to Stress
Raben, N., & Puertollano, R. (2016) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-111315-125407 · Cited by 437 · cited 1×
“Notably, transcription factor EB (TFEB) and transcription factor enhancer 3 (TFE3) are also involved in the formation of autolysosomes (50).”
BackgroundNAFLD: Mechanisms, Treatments, and Biomarkers
Nassir, F. (2022) · Biomolecules · doi:10.3390/biom12060824 · Cited by 405
Autophagy in metabolic disease and ageing
Kitada, M., & Koya, D. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00551-9 · Cited by 399 · cited 1×
“…is an important process for maintaining cellular homeostasis, and forms autophagosomes by degrading unnecessary organelles, proteins and other components in cells, and forms autolysosomes by combining with lysosomes to eliminate phagocytized goods and maintain intracellular homeostasis (13, 14).”
BackgroundAutophagy in liver diseases: Time for translation?
Allaire, M., Rautou, P.-E., Codogno, P., & Lotersztajn, S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.01.026 · Cited by 378
Autophagy in liver diseases: A review
Qian, H., Chao, X., Williams, J., Fulte, S., Li, T., Yang, L., & Ding, W.-X. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.100973 · Cited by 373 · cited 1×
“This makes it one of the important targets for treating NAFLD (20, 21).”
BackgroundBadmus, O. O., Hillhouse, S. A., Anderson, C. D., Hinds, T. D., & Stec, D. E. (2022) · Clinical Science · doi:10.1042/cs20220572 · Cited by 370 · cited 3×
“In NAFLD, the increased lipolysis in the liver leads to the excessive release of FFA, which stimulates lipid accumulation and degeneration in hepatocytes, triggers mitochondrial dysfunction, activates ERS, and results in lipid peroxidation in the liver (8, 9).”
BackgroundInfluentialRole of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease
Hammoutene, A., & Rautou, P.-E. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.012 · Cited by 364
The ménage à trois of autophagy, lipid droplets and liver disease
Filali-Mouncef, Y., Hunter, C., Roccio, F., Zagkou, S., Dupont, N., Primard, C., Proikas-Cezanne, T., & Reggiori, F. (2022) · Autophagy · doi:10.1080/15548627.2021.1895658 · Cited by 361
ER-Phagy: Selective Autophagy of the Endoplasmic Reticulum
Bernales, S., Schuck, S., & Walter, P. (2007) · Autophagy · doi:10.4161/auto.3930 · Cited by 356
Kumar, S., Duan, Q., Wu, R., Harris, E. N., & Su, Q. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113869 · Cited by 351
Lipid droplet size directs lipolysis and lipophagy catabolism in hepatocytes
Schott, M. B., Weller, S. G., Schulze, R. J., Krueger, E. W., Drizyte-Miller, K., Casey, C. A., & McNiven, M. A. (2019) · Journal of Cell Biology · doi:10.1083/jcb.201803153 · Cited by 348 · cited 1×
“Thus, adipose triglyceride lipase (ATGL) is a cytosolic lipase involved in lipolysis, which releases free fatty acids (FFAs) that can serve as substrates for mitochondrial b -oxidation or as potent signaling molecules for various cellular processes (60).”
BackgroundAutophagy and Lipid Droplets in the Liver
Martinez-Lopez, N., & Singh, R. (2015) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071813-105336 · Cited by 333 · cited 1×
“Restoring autophagy can promote the breakdown of fat, improve hepatic steatosis, and reduce liver cell damage (19).”
BackgroundSong, Y. M., Lee, Y.-H., Kim, J.-W., Ham, D.-S., Kang, E.-S., Cha, B. S., Lee, H. C., & Lee, B.-W. (2015) · Autophagy · doi:10.4161/15548627.2014.984271 · Cited by 332
Two ubiquitin-like conjugation systems that mediate membrane formation during autophagy
Nakatogawa, H. (2013) · Essays in Biochemistry · doi:10.1042/bse0550039 · Cited by 314
Current treatment paradigms and emerging therapies for NAFLD/NASH
Raza, S. (2021) · Frontiers in Bioscience · doi:10.2741/4892 · Cited by 310 · cited 1×
“The traditional treatment of NAFLD focuses on addressing pathological changes caused by excessive fatty accumulation through exercise, dietary adjustments, lifestyle improvements, and reduction of liver fat accumulation (6, 7).”
BackgroundZhang, S., Peng, X., Yang, S., Li, X., Huang, M., Wei, S., Liu, J., He, G., Zheng, H., Yang, L., et al. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-04593-3 · Cited by 306
Proliferating Cholangiocytes: A Neuroendocrine Compartment in the Diseased Liver
Alvaro, D., Mancino, M. G., Glaser, S., Gaudio, E., Marzioni, M., Francis, H., & Alpini, G. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.07.023 · Cited by 304 · cited 1×
“This leads to manifestations such as proliferation promotion, in fl ammation promotion, fi brosis promotion, or aging (135, 136).”
BackgroundNasiri-Ansari, N., Nikolopoulou, C., Papoutsi, K., Kyrou, I., Mantzoros, C. S., Kyriakopoulos, G., Chatzigeorgiou, A., Kalotychou, V., Randeva, M. S., Chatha, K., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020818 · Cited by 297
Dissecting the role of the Atg12–Atg5-Atg16 complex during autophagosome formation
Walczak, M., & Martens, S. (2013) · Autophagy · doi:10.4161/auto.22931 · Cited by 294 · cited 1×
“Subsequently, the ubiquitin-like binding of E1 activase enzyme ATG7, the E2 binding enzyme ATG3, and the E3 ligase ATG12-ATG5-ATG16L1 activates LC3I and facilitates its interaction with phosphatidylethanolamine (PE) to form lipidized ATG8/LC3-II (39 – 42).”
BackgroundHepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis
Gao, J., Wei, B., de Assuncao, T. M., Liu, Z., Hu, X., Ibrahim, S., Cooper, S. A., Cao, S., Shah, V. H., & Kostallari, E. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.044 · Cited by 288
Luo, W., Xu, Q., Wang, Q., Wu, H., & Hua, J. (2017) · Scientific Reports · doi:10.1038/srep44612 · Cited by 282 · cited 1×
“In addition, hepatic macrophages function by undergoing classical M1 activation or M2 activation (101).”
BackgroundEndoplasmic reticulum stress-mediated cell death in liver injury
Zhang, J., Guo, J., Yang, N., Huang, Y., Hu, T., & Rao, C. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-05444-x · Cited by 281 · cited 1×
“By upregulating ER autophagy receptors, UPR promotes autophagy, and C/EBP homologous protein (CHOP) plays a critical regulatory role in this process (80, 81).”
Background(2006) · Hepatology · doi:10.1002/(issn)1527-3350 · Cited by 262
Pivotal role of liver sinusoidal endothelial cells in NAFLD/NASH progression
Miyao, M., Kotani, H., Ishida, T., Kawai, C., Manabe, S., Abiru, H., & Tamaki, K. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.95 · Cited by 254
Pathak, P., Liu, H., Boehme, S., Xie, C., Krausz, K. W., Gonzalez, F., & Chiang, J. Y. L. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.784322 · Cited by 253
Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD
Pasarín, M., La Mura, V., Gracia-Sancho, J., García-Calderó, H., Rodríguez-Vilarrupla, A., García-Pagán, J. C., Bosch, J., & Abraldes, J. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032785 · Cited by 247 · cited 1×
“Conversely, the dysfunction of LSECs are an early event in the progression of NAFLD, leading to impaired hepatic lipid uptake and metabolism, in fl ammation, and hepatocyte damage (120 – 122).”
BackgroundNon-alcoholic fatty liver disease: Definition and subtypes
Han, S. K., Baik, S. K., & Kim, M. Y. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0424 · Cited by 245
Fujita, K., Nozaki, Y., Wada, K., Yoneda, M., Fujimoto, Y., Fujitake, M., Endo, H., Takahashi, H., Inamori, M., Kobayashi, N., et al. (2009) · Hepatology · doi:10.1002/hep.23094 · Cited by 244
Regulation of autophagy by canonical and non-canonical ER stress responses
Bhardwaj, M., Leli, N. M., Koumenis, C., & Amaravadi, R. K. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.11.007 · Cited by 244
Non‐alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management
Huang, T. (., Behary, J., & Zekry, A. (2020) · Internal Medicine Journal · doi:10.1111/imj.14709 · Cited by 227
Wang, R., Ding, Q., Yaqoob, U., de Assuncao, T. M., Verma, V. K., Hirsova, P., Cao, S., Mukhopadhyay, D., Huebert, R. C., & Shah, V. H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.671735 · Cited by 222
Byun, S., Seok, S., Kim, Y.-C., Zhang, Y., Yau, P., Iwamori, N., Xu, H. E., Ma, J., Kemper, B., & Kemper, J. K. (2020) · Nature Communications · doi:10.1038/s41467-020-14384-z · Cited by 219
Nagahashi, M., Takabe, K., Liu, R., Peng, K., Wang, X., Wang, Y., Hait, N. C., Wang, X., Allegood, J. C., Yamada, A., et al. (2015) · Hepatology · doi:10.1002/hep.27592 · Cited by 211
Activation and targeting of ATG8 protein lipidation
Martens, S., & Fracchiolla, D. (2020) · Cell Discovery · doi:10.1038/s41421-020-0155-1 · Cited by 209 · cited 1×
“Subsequently, the ubiquitin-like binding of E1 activase enzyme ATG7, the E2 binding enzyme ATG3, and the E3 ligase ATG12-ATG5-ATG16L1 activates LC3I and facilitates its interaction with phosphatidylethanolamine (PE) to form lipidized ATG8/LC3-II (39 – 42).”
BackgroundLiu, B., Deng, X., Jiang, Q., Li, G., Zhang, J., Zhang, N., Xin, S., & Xu, K. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109895 · Cited by 200
Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options
Grander, C., Grabherr, F., & Tilg, H. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad095 · Cited by 199 · cited 1×
“The traditional treatment of NAFLD focuses on addressing pathological changes caused by excessive fatty accumulation through exercise, dietary adjustments, lifestyle improvements, and reduction of liver fat accumulation (6, 7).”
BackgroundShu, F., Xiao, H., Li, Q.-N., Ren, X.-S., Liu, Z.-G., Hu, B.-W., Wang, H.-S., Wang, H., & Jiang, G.-M. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01300-8 · Cited by 192
Cellular Sources of Extracellular Matrix in Hepatic Fibrosis
Wells, R. G. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.008 · Cited by 191
Yan, L.-S., Zhang, S.-F., Luo, G., Cheng, B. C.-Y., Zhang, C., Wang, Y.-W., Qiu, X.-Y., Zhou, X.-H., Wang, Q.-G., Song, X.-L., et al. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155200 · Cited by 179
Zheng, Y., Wang, S., Wu, J., & Wang, Y. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04367-1 · Cited by 179 · cited 2×
“On the contrary, dysregulation of autophagy weakens lipolysis and fat phagocytosis in hepatocytes, leading to mitochondrial dysfunction and increased production of reactive oxygen species (ROS) in the liver (56).”
BackgroundSelf-citationWang, S., Li, K., Pickholz, E., Dobie, R., Matchett, K. P., Henderson, N. C., Carrico, C., Driver, I., Borch Jensen, M., Chen, L., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.add3949 · Cited by 176
Self-citationTherapeutic regulation of autophagy in hepatic metabolism
Byrnes, K. G., Blessinger, S. A., Bailey, N. T., Scaife, R., Liu, G., & Khambu, B. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.07.021 · Cited by 169
ER ‐phagy: selective autophagy of the endoplasmic reticulum
Mochida, K., & Nakatogawa, H. (2022) · EMBO reports · doi:10.15252/embr.202255192 · Cited by 169
SQSTM1/p62 promotes mitochondrial ubiquitination independently of PINK1 and PRKN/parkin in mitophagy
Yamada, T., Dawson, T. M., Yanagawa, T., Iijima, M., & Sesaki, H. (2019) · Autophagy · doi:10.1080/15548627.2019.1643185 · Cited by 168 · cited 1×
“Parkin ubiquitinates outer membrane proteins and recruits P62 to damaged mitochondria, resulting in changes in autophagosome membrane structure and initiating selective mitophagy (69, 70).”
BackgroundDysfunction of autophagy in high-fat diet-induced non-alcoholic fatty liver disease
Ren, Q., Sun, Q., & Fu, J. (2023) · Autophagy · doi:10.1080/15548627.2023.2254191 · Cited by 163
Zhu, X., Xiong, T., Liu, P., Guo, X., Xiao, L., Zhou, F., Tang, Y., & Yao, P. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.02.019 · Cited by 161 · cited 1×
“It also stimulates autophagy to ameliorate HFD-induced NAFLD (186).”
BackgroundZheng, X., Dai, W., Chen, X., Wang, K., Zhang, W., Liu, L., & Hou, J. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-015-0206-3 · Cited by 152
Self-citationGLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway
He, Q., Sha, S., Sun, L., Zhang, J., & Dong, M. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.05.086 · Cited by 151
Reactive Oxygen Species and Oxidative Stress in the Pathogenesis of MAFLD
Clare, K., Dillon, J. F., & Brennan, P. N. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00067 · Cited by 150
The Endothelium as a Driver of Liver Fibrosis and Regeneration
Lafoz, E., Ruart, M., Anton, A., Oncins, A., & Hernández-Gea, V. (2020) · Cells · doi:10.3390/cells9040929 · Cited by 149
Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β
Hart, K. M., Fabre, T., Sciurba, J. C., Gieseck, R. L., Borthwick, L. A., Vannella, K. M., Acciani, T. H., de Queiroz Prado, R., Thompson, R. W., White, S., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal3694 · Cited by 143
Li, X., Shi, Z., Zhu, Y., Shen, T., Wang, H., Shui, G., Loor, J. J., Fang, Z., Chen, M., Wang, X., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15083 · Cited by 143
AMPK: a key regulator of energy stress and calcium-induced autophagy
Saikia, R., & Joseph, J. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02125-8 · Cited by 138 · cited 2×
“When autophagy is initiated, AMPK is regulated by upstream kinases such as liver kinase B1 (LKB1) and calcium/calmodulin-dependent protein kinase kinase 2 or b (CaMKK2/ b ), while simultaneously inhibiting the expression of mammalian target of rapamycin 1 (mTOR1) (29, 30).”
BackgroundYoo, J. H., Jeong, I., Ahn, K. J., Chung, H. Y., & Hwang, Y. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154798 · Cited by 137 · cited 1×
“The PPAR a agonist feno fi brate activates lysosomal Ca 2+ via mucolipin 1, leading to stimulates the calcineurin phosphatase and CaMKK b - AMPK-ULK1 signaling pathways (184).”
BackgroundKupffer Cells in Non-alcoholic Fatty Liver Disease: Friend or Foe?
Chen, J., Deng, X., Liu, Y., Tan, Q., Huang, G., Che, Q., Guo, J., & Su, Z. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.47143 · Cited by 135
Zeng, J., Acin-Perez, R., Assali, E. A., Martin, A., Brownstein, A. J., Petcherski, A., Fernández-del-Rio, L., Xiao, R., Lo, C. H., Shum, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38165-6 · Cited by 134
Dapagliflozin Alleviates Hepatic Steatosis by Restoring Autophagy via the AMPK-mTOR Pathway
Li, L., Li, Q., Huang, W., Han, Y., Tan, H., An, M., Xiang, Q., Zhou, R., Yang, L., & Cheng, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.589273 · Cited by 133
Fatty acid activates NLRP3 inflammasomes in mouse Kupffer cells through mitochondrial DNA release
Pan, J., Ou, Z., Cai, C., Li, P., Gong, J., Ruan, X. Z., & He, K. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.08.006 · Cited by 132
Endothelial Cell Dysfunction and Nonalcoholic Fatty Liver Disease (NAFLD): A Concise Review
Nasiri-Ansari, N., Androutsakos, T., Flessa, C.-M., Kyrou, I., Siasos, G., Randeva, H. S., Kassi, E., & Papavassiliou, A. G. (2022) · Cells · doi:10.3390/cells11162511 · Cited by 131
Meng, Z., Liu, X., Li, T., Fang, T., Cheng, Y., Han, L., Sun, B., & Chen, L. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107492 · Cited by 128
Lipophagy and Lipolysis Status in Lipid Storage and Lipid Metabolism Diseases
Kłoska, A., Węsierska, M., Malinowska, M., Gabig‐Cimińska, M., & Jakóbkiewicz‐Banecka, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176113 · Cited by 127
Fang, Y., Ji, L., Zhu, C., Xiao, Y., Zhang, J., Lu, J., Yin, J., & Wei, L. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.602574 · Cited by 108
Functional and Structural Features of Cholangiocytes in Health and Disease
Maroni, L., Haibo, B., Ray, D., Zhou, T., Wan, Y., Meng, F., Marzioni, M., & Alpini, G. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.05.005 · Cited by 107 · cited 1×
“The epithelium of intra-and extra-hepatic bile ducts is lined with cholangiocytes, which include two distinct types, small and large (129, 130).”
BackgroundCheng, X., Ma, X., Ding, X., Li, L., Jiang, X. M., Shen, Z., Chen, S., Liu, W., Gong, W., & Sun, Q. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.02.010 · Cited by 105
Self-citationAbreu, S., Kriegenburg, F., Gómez‐Sánchez, R., Mari, M. C., Sánchez, J., Rasmussen, M. S., Guimarães, R. S., Zens, B., Schuschnig, M., Hardenberg, R., et al. (2017) · EMBO Reports · doi:10.15252/embr.201643146 · Cited by 103
Advances in the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease
Yin, X., Guo, X., Liu, Z., & Wang, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032844 · Cited by 102 · cited 1×
“NAFLD is a common chronic liver disease characterized by excessive accumulation of hepatic fat in the absence of chronic viral infection and alcohol abuse (1, 2).”
BackgroundDu, X., Malta, C. D., Fang, Z., Shen, T., Niu, X., Chen, M., Jin, B., Yu, H., Lei, L., Gao, W., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.12.012 · Cited by 99
The TBC/RabGAP Armus Coordinates Rac1 and Rab7 Functions during Autophagy
Carroll, B., Mohd-Naim, N., Maximiano, F., Frasa, M. A., McCormack, J., Finelli, M., Thoresen, S. B., Perdios, L., Daigaku, R., Francis, R. E., et al. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.03.005 · Cited by 98
Zhang, C.-Y., Tan, X., Yang, H., Jin, L., Hong, J., Zhou, Y., & Huang, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158267 · Cited by 98
Major roles of kupffer cells and macrophages in NAFLD development
Park, S., Diaz, J. G., Um, E., & Hahn, Y. S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1150118 · Cited by 98 · cited 1×
“There is an increasing body of evidence suggesting that hepatic macrophages play a crucial role in the development of NAFLD (103 – 105).”
BackgroundCao, Y., Mai, W., Li, R., Deng, S., Li, L., Zhou, Y., Qin, Q., Zhang, Y., Zhou, X., Han, M., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04319-w · Cited by 97
Jaber, N., Mohd-Naim, N., Wang, Z., DeLeon, J. L., Kim, S., Zhong, H., Sheshadri, N., Dou, Z., Edinger, A. L., Du, G., et al. (2016) · Journal of Cell Science · doi:10.1242/jcs.192260 · Cited by 91 · cited 2×
“In conjunction with the HOPS complex, VPS34 complex II and Rab7 further regulate this process, enabling fusion between cargo-containing autophagosome sand lysosomes (45, 47, 48).”
BackgroundMaresin 1 attenuates NAFLD by suppression of endoplasmic reticulum stress via AMPK–SERCA2b pathway
Jung, T. W., Kim, H., El‐Aty, A. M. A., & Jeong, J. H. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000885 · Cited by 91
Relevance of Autophagy in Parenchymal and Non-Parenchymal Liver Cells for Health and Disease
Weiskirchen, R., & Tacke, F. (2019) · Cells · doi:10.3390/cells8010016 · Cited by 91
Qi, X., Song, A., Ma, M., Wang, P., Zhang, X., Lu, C., Zhang, J., Zheng, S., & Jin, H. (2021) · Cell Proliferation · doi:10.1111/cpr.13107 · Cited by 91 · cited 1×
“Additional studies with curcumin, 1,3-dichloro-2-propanol, icariin, baicalein, and verapamil have elucidated its effects on autophagic processes in hepatocyte models of NAFLD (157 – 161).”
BackgroundLiu, B., Deng, X., Jiang, Q., Li, G., Zhang, J., Zhang, N., Xin, S., & Xu, K. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105797 · Cited by 90
Toward the function of mammalian ATG12–ATG5-ATG16L1 complex in autophagy and related processes
Lystad, A. H., Carlsson, S. R., & Simonsen, A. (2019) · Autophagy · doi:10.1080/15548627.2019.1618100 · Cited by 89 · cited 2×
“Concurrently, the induction of WIPI and ATG16L1 triggers the formation of two downstream ubiquitin complexes: ATG12-ATG5-ATG16L1 and LC3-II (33, 35, 37, 38).”
BackgroundWu, H., Chen, G., Wang, J., Deng, M., Yuan, F., & Gong, J. (2020) · Cell Proliferation · doi:10.1111/cpr.12731 · Cited by 89
Xiu, A., Ding, Q., Li, Z., & Zhang, C. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s317701 · Cited by 88 · cited 1×
“Doxazosin has been observed to inhibit autophagy by stimulating the PI3K/Akt/mTOR pathway, attenuating liver fi brosis (162).”
BackgroundMechanisms of cholangiocyte responses to injury
Sato, K., Meng, F., Giang, T., Glaser, S., & Alpini, G. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.06.017 · Cited by 87 · cited 1×
“In the physiological state, cholangiocytes have a low proliferative capacity and are in a mitotic quiescent phase (131).”
BackgroundQi, Q., Niture, S. K., Gadi, S. V., Arthur, E., Moore, J. T., Levine, K. E., & Kumar, D. (2022) · Environmental Toxicology · doi:10.1002/tox.23680 · Cited by 87
Mukhopadhyay, S., Schlaepfer, I. R., Bergman, B. C., Panda, P. K., Praharaj, P. P., Naik, P. P., Agarwal, R., & Bhutia, S. K. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.007 · Cited by 86
Boukhalfa, A., Nascimbeni, A. C., Ramel, D., Dupont, N., Hirsch, E., Gayral, S., Laffargue, M., Codogno, P., & Morel, E. (2020) · Nature Communications · doi:10.1038/s41467-019-14086-1 · Cited by 81
Macia, M. G., Santos‐Ledo, A., Leslie, J., Paish, H. L., Collins, A., Scott, R., Watson, A. A., Burgoyne, R. A., White, S. A., French, J., et al. (2021) · Hepatology · doi:10.1002/hep.32048 · Cited by 81
Sun, C., Zhang, J., Hou, J., Hui, M., Qi, H., Lei, T., Zhang, X., Zhao, L., & Du, H. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114005 · Cited by 81
LAMP3 regulates hepatic lipid metabolism through activating PI3K/Akt pathway
Liao, X., Song, L., Zhang, L., Wang, H., Tong, Q., Xu, J., Yang, G., Yang, S., & Zheng, H. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.10.010 · Cited by 80 · cited 1×
“The upregulation of lysosome-associated membrane protein 3 (LAMP3) in patients with NAFLD and in mouse models has been correlated with the activation of the PI3K/Akt pathway, which facilitates autolysosome fusion (188).”
BackgroundHepatic Stellate Cells: Dictating Outcome in Nonalcoholic Fatty Liver Disease
Wiering, L., Subramanian, P., & Hammerich, L. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.02.010 · Cited by 80 · cited 1×
“However, activation of HSCs enhances extracellular matrix (ECM) production, which is a key initiating event in hepatic fi brosis and plays a crucial role in NAFLD progression (109, 110).”
BackgroundHepatic Stellate Cell-Immune Interactions in NASH
Carter, J. K., & Friedman, S. L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.867940 · Cited by 79 · cited 1×
“Activated HSCs contribute to in fl ammation and fi brosis in NAFLD by secreting proin fl ammatory cytokines and expressing adhesion molecules that promote the recruitment and in fi ltration of immune cells into the liver (113).”
BackgroundPark, J.-M., Rah, S., An, H. S., Lee, J. Y., Roh, G. S., Ryter, S. W., Park, J. W., Yang, C. H., Surh, Y., Kim, U., et al. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155516 · Cited by 79
Luo, X., Luo, S., Xu, Z., Zhou, C., Li, Z., Zhou, X., & Xu, M. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i14.1419 · Cited by 76
Atg2 and Atg9: Intermembrane and interleaflet lipid transporters driving autophagy
Noda, N. N. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.158956 · Cited by 74 · cited 2×
“Concurrently, the induction of WIPI and ATG16L1 triggers the formation of two downstream ubiquitin complexes: ATG12-ATG5-ATG16L1 and LC3-II (33, 35, 37, 38).”
BackgroundHe, K., Zhu, X., Liu, Y., Miao, C., Wang, T., Li, P., Zhao, L., Chen, Y., Gong, J., Cai, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17489 · Cited by 73 · cited 1×
“There is an increasing body of evidence suggesting that hepatic macrophages play a crucial role in the development of NAFLD (103 – 105).”
BackgroundZhou, H., Ma, C., Wang, C., Gong, L., Zhang, Y., & Li, Y. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173976 · Cited by 73 · cited 2×
“In recent years, there have been reports discussing drugs that target autophagy for the treatment of NAFLD, including herbal extracts, emerging GLP-1 activators, and SGLT2 inhibitors (91).”
BackgroundRole of liver sinusoidal endothelial cell in metabolic dysfunction-associated fatty liver disease
He, Q., He, W., Dong, H., Guo, Y., Yuan, G., Shi, X., Wang, D., & Lu, F. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01720-9 · Cited by 73
Xiong, J., Wang, K., He, J., Zhang, G., Zhang, D., & Chen, F. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030387 · Cited by 69
Undamatla, R., Fagunloye, O. G., Chen, J., Edmunds, L. R., Murali, A., Mills, A., Xie, B., Pangburn, M. M., Sipula, I., Gibson, G., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-34710-x · Cited by 68
Autophagy Dysregulation in Metabolic Associated Fatty Liver Disease: A New Therapeutic Target
Chen, C., & Lin, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710055 · Cited by 66 · cited 1×
“Emerging therapeutic drugs, such as glucagon-like peptide-1 (GLP-1), sodium glucose co-transporter 2 (SGLT2) inhibitors, and immune-related GTPase M (IRGM), have been studied extensively (90).”
BackgroundWu, P., Zhao, J., Guo, Y., Yu, Y., Wu, X., & Xiao, H. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.05.128 · Cited by 64
Zhang, H., Lu, J. F., Liu, H., Guan, L., Xu, S., Wang, Z., Qiu, Y., Liu, H., Peng, L., & Men, X. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105964 · Cited by 64 · cited 1×
“Ajugol, an active alkaloid derived from the root of rehmanniobium, effectively inhibits mTOR and induces the nuclear translocation of TFEB, promoting the restoration of the autophagy-lysosomal pathway and lipophagy (191).”
BackgroundSharma, A., Anand, S. K., Singh, N., Dwarkanath, A., Dwivedi, U. N., & Kakkar, P. (2021) · Food & Function · doi:10.1039/d0fo02501a · Cited by 61
Wu, C., Jing, M., Yang, L., Lei, J., Ding, Y., Lu, J., Cao, Q., & Jiang, Y. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.06.005 · Cited by 59
Palmitic acid elicits hepatic stellate cell activation through inflammasomes and hedgehog signaling
Duan, N.-N., Liu, X.-J., & Wu, J. H. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.03.012 · Cited by 57 · cited 1×
“Conversely, PA induces HSC activation through the NLRP3 in fl ammasome and Hedgehog (Hh) signaling pathways, diminishing autophagic fl ux, inhibiting autophagy, and promoting the progression of NASH toward fi brosis (174).”
BackgroundZhou, T., Wu, N., Meng, F., Venter, J., Giang, T. K., Francis, H., Kyritsi, K., Wu, C., Franchitto, A., Alvaro, D., et al. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0093-9 · Cited by 57
New aspects of hepatic endothelial cells in physiology and nonalcoholic fatty liver disease
Sun, X., & Harris, E. N. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00062.2020 · Cited by 57
McMahan, R. H., Porsche, C. E., Edwards, M. G., & Rosen, H. R. (2016) · PLOS ONE · doi:10.1371/journal.pone.0159217 · Cited by 55
Zhou, W., Yan, X., Zhai, Y., Liu, H., Guan, L., Qiao, Y., Jiang, J., & Peng, L. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154235 · Cited by 52 · cited 1×
“Phillygenin reduces hepatocyte lipid deposition by regulating the Ca 2+ calcineurin-TFEB axis, thereby enhancing lysosomal biogenesis and autophagic fl ux (187).”
BackgroundPathobiology of biliary epithelia
Cheung, A., Pisarello, M. J. L., & LaRusso, N. F. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.06.024 · Cited by 51
Acetaminophen aggravates fat accumulation in NAFLD by inhibiting autophagy via the AMPK/mTOR pathway
Shi, C., Xue, W., Han, B., Yang, F., Yin, Y., & Hu, C. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.02.005 · Cited by 51
Kuo, N.-C., Huang, S.-Y., Yang, C., Shen, H., & Lee, Y. (2020) · Antioxidants · doi:10.3390/antiox9100924 · Cited by 50
Tim-4 Inhibits NLRP3 Inflammasome via the LKB1/AMPKα Pathway in Macrophages
Liu, W., Bai, F., Wang, H., Liang, Y., Du, X., Liu, C., Cai, D., Peng, J., Zhong, G., Liang, X., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900117 · Cited by 49
Emerging Roles of Impaired Autophagy in Fatty Liver Disease and Hepatocellular Carcinoma
Niture, S. K., Lin, M., Ríos-Colón, L., Qi, Q., Moore, J. T., & Kumar, D. (2021) · International Journal of Hepatology · doi:10.1155/2021/6675762 · Cited by 48 · cited 1×
“This process is important in the treatment of NAFLD (67, 68).”
BackgroundAescin can alleviate NAFLD through Keap1-Nrf2 by activating antioxidant and autophagy
Yu, H., Yan, S., Jin, M., Wei, Y., Zhao, L., Cheng, J., Ding, L., & Feng, H. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154746 · Cited by 47
Suflețel, R. T., Melincovici, C. S., Gheban, B., Zaharie, T., & Mihu, C. M. (2021) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.61.3.01 · Cited by 46
Fan, Y., Dong, W., Wang, Y., Zhu, S., Chai, R., Xu, Z., Zhang, X., Yan, Y., Yang, L., & Bian, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.959495 · Cited by 45 · cited 1×
“Glycyrrhizic acid has been demonstrated to enhance impaired autophagy fl ux, mitigate excessive production of in fl ammatory cytokines, and ameliorate hepatocyte apoptosis through the regulation of the STAT3-HIF-1 a pathway in macrophages (172).”
BackgroundChiba, M., Sasaki, M., Kitamura, S., Ikeda, H., Sato, Y., & Nakanuma, Y. (2011) · Journal of Clinical Pathology · doi:10.1136/jcp.2011.090175 · Cited by 43
Emerging mechanistic insights of selective autophagy in hepatic diseases
Al‐Bari, M. A. A., Ito, Y., Thomes, P. G., Menon, M. B., Macia, M. G., Fadel, R. A., Stadlin, A., Peake, N., Faris, M. E., Eid, N. A. S., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1149809 · Cited by 42 · cited 2×
“However, improving speci fi c selective autophagy can alleviate the progression of NAFLD (57).”
Zhang, X., Huo, Z., Luan, H., Huang, Y., Shen, Y., Sheng, L., Liang, J.-Y., & Wu, F. (2021) · Phytotherapy Research · doi:10.1002/ptr.7344 · Cited by 41
Wang, X.-K., & Peng, Z.-G. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.655557 · Cited by 40 · cited 1×
“Conversely, the dysfunction of LSECs are an early event in the progression of NAFLD, leading to impaired hepatic lipid uptake and metabolism, in fl ammation, and hepatocyte damage (120 – 122).”
BackgroundLi, Y., Li, X., Wang, Y.-D., Shen, C., & Zhao, C.-Y. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.077 · Cited by 36
Inhibition of Secretin/Secretin Receptor Axis Ameliorates NAFLD Phenotypes
Chen, L., Wu, N., Kennedy, L. L., Francis, H., Ceci, L., Zhou, T., Samala, N. R., Kyritsi, K., Wu, C., Sybenga, A. B., et al. (2021) · Hepatology · doi:10.1002/hep.31871 · Cited by 35 · cited 1×
“Research has shown that cholangiocytes promote hepatic steatosis by upregulating lipid biosynthesis genes by regulating the SCT/ SCTR/miR-125b axis, which is crucial for improving the phenotype of NAFLD/NASH in humans (139).”
BackgroundMetabolic Role of Autophagy in the Pathogenesis and Development of NAFLD
An, L., Wirth, U., Koch, D. T., Schirren, M., Drefs, M., Koliogiannis, D., Nieß, H., Andrassy, J., Guba, M. O., Bazhin, A. V., et al. (2023) · Metabolites · doi:10.3390/metabo13010101 · Cited by 35
WIPI proteins: Biological functions and related syndromes
Almannai, M., Marafi, D., & El‐Hattab, A. W. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1011918 · Cited by 34 · cited 6×
“Concurrently, the induction of WIPI and ATG16L1 triggers the formation of two downstream ubiquitin complexes: ATG12-ATG5-ATG16L1 and LC3-II (33, 35, 37, 38).”
BackgroundInfluentialAutophagy in the liver: cell’s cannibalism and beyond
Flores‐Toro, J., Go, K. L., Leeuwenburgh, C., & Js, K. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0807-8 · Cited by 33
An, X., Liu, J., Li, Y., Dou, Z., Li, N., Suo, Y., Ma, Y., Sun, M., Tian, Z., & Xu, L. (2020) · Peptides · doi:10.1016/j.peptides.2020.170422 · Cited by 33
Zhu, X., Yao, P., Liu, J., Guo, X., Jiang, C., & Tang, Y. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110990 · Cited by 30 · cited 1×
“Baicalein has been found to inhibit the mTOR signaling pathway, enhance lysosomal membrane permeability, and restore autophagy, offering a therapeutic strategy for NAFLD (190).”
BackgroundZeng, J., Zhu, B., & Su, M. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.07.094 · Cited by 28 · cited 1×
“Compounds such as schisandrin B and acetylshikonin (AS) activate the AMPK/mTOR pathway, stimulating hepatocyte autophagy and attenuating NAFLD progression (140, 141).”
BackgroundZhang, J., Jian, P., Jiang, N., & Xu, L. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14463 · Cited by 28
Chen, X., Xue, W., Zhang, J., Peng, J., & Huang, W. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01787-2 · Cited by 28
Self-citationJiang, N., Zhang, J., Jian, P., & Xu, L.-M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.938856 · Cited by 27
Yu, Z., Xie, X., Su, X., Lv, H., Song, S., Liu, C., You, Y., Tian, M., Zhu, L., Wang, L., et al. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110304 · Cited by 25
Zheng, Y., Wang, M., Shu, X., Zheng, P., & Ji, G. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i9.992 · Cited by 24 · cited 1×
“…signaling pathway resulted in the induction of autophagosomes or their co-localization with lysosomes, this led to autophagosomal degradation, activation of the autophagy process, reduction in oxidative stress levels, and improvement in lipid accumulation and in fl ammatory response (189).”
BackgroundMAPK p38/Ulk1 pathway inhibits autophagy and induces IL-1β expression in hepatic stellate cells
Jin, L., Li, J., Yang, S., Zhang, R., Hu, C., Chen, Y., Tian, Z., Ma, W., Feng, Y., Liu, N., et al. (2022) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00230.2021 · Cited by 24 · cited 1×
“Additionally, in LPS-induced HSC-T6 cells, activation of the MAPK p38/Ulk1 pathway inhibits autophagy in HSCs and induces IL-1 b expression (173).”
BackgroundSelf-citationHao, T., Chen, H., Wu, S., & Tian, H. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10304 · Cited by 23
Popelka, H., Reinhart, E. F., Metur, S. P., Leary, K. A., Ragusa, M. J., & Klionsky, D. J. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.166809 · Cited by 23 · cited 2×
“Concurrently, the induction of WIPI and ATG16L1 triggers the formation of two downstream ubiquitin complexes: ATG12-ATG5-ATG16L1 and LC3-II (33, 35, 37, 38).”
BackgroundZhou, T., Kundu, D., Robles-Linares, J., Meadows, V., Sato, K., Baiocchi, L., Ekser, B., Glaser, S., Alpini, G., Francis, H., et al. (2021) · Cells · doi:10.3390/cells10082072 · Cited by 23
Verapamil induces autophagy to improve liver regeneration in non-alcoholic fatty liver mice
Lai, J., Lian, Y., Wu, J., Wang, Y.-D., & Bai, Y. (2021) · Adipocyte · doi:10.1080/21623945.2021.1983241 · Cited by 21
Shu, Y., He, Y., Ye, G.-R., Liu, X., Huang, J., Zhang, Q., Tian, D., Wang, T., & Shu, J.-C. (2023) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30487 · Cited by 19
Qin, L., Tan, J., Lv, X., & Zhang, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115673 · Cited by 18
UBE3A deficiency-induced autophagy is associated with activation of AMPK-ULK1 and p53 pathways
Hao, X., Sun, J., Zhong, L., Baudry, M., & Bi, X. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114358 · Cited by 16 · cited 1×
“Subsequently, AMPK phosphorylates the downstream UNC-51-like kinase 1 (ULK1) complex, which serves as the initiation kinase complex of autophagy and primarily consists of ATG13, FIP200, ATG101, ULK1 or ULK2 in mammals (31, 32).”
BackgroundHa, K. B., Lee, E. S., Park, N. W., Jo, S. H., Shim, S., Kim, D., Ahn, C. M., & Chung, C. H. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2022.0110 · Cited by 15
Wu, Y., Yang, Y., Li, F., Zou, J., Wang, Y., Xu, M., Wang, Y., Li, R., Sun, Y., Lu, S., et al. (2021) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00050 · Cited by 13
Huan, S., Sun, S., Song, S., Dai, J., Zhu, G., Zhong, Y., Ji, Y., Zheng, S., & Yin, G. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5243 · Cited by 13
Wu, Y., Yin, A.-H., Sun, J., Xu, W.-H., & Zhang, C. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i33.4975 · Cited by 13
The hookup model of the HOPS complex in autophagosome-lysosome fusion
Zhang, S., Li, L., Liu, X., & Zhong, Q. (2023) · Autophagy · doi:10.1080/15548627.2023.2291938 · Cited by 13 · cited 3×
“In conjunction with the HOPS complex, VPS34 complex II and Rab7 further regulate this process, enabling fusion between cargo-containing autophagosome sand lysosomes (45, 47, 48).”
BackgroundYao, J., & Zhao, Y. (2023) · PeerJ · doi:10.7717/peerj.15639 · Cited by 12 · cited 1×
“…silencing lipoprotein-associated phospholipase A2 (Lp-PLA2) in KCs and NAFLD model mice inhibited the activation of the JAK2/STAT3 signaling pathway, mitigated lipid accumulation, promoted autophagy, reduced production of in fl ammatory factors, and inhibited the progression of NAFLD (179).”
BackgroundFan, Y., Lu, J., Liu, J., Zhang, R., Yu, Z., & Guan, S. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112578 · Cited by 10
Self-citationAlavifard, H., Mazhari, S., Meyfour, A., Tokhanbigli, S., Ghavami, S., Zali, M. R., Aghdaei, H. A., Hatami, B., & Baghaei, K. (2023) · Cell Biology International · doi:10.1002/cbin.11992 · Cited by 10 · cited 1×
“In the mouse model of HSCs, imatinib speci fi cally targeted the STAT3/IL-6 pathway via miR-124, leading to the induction of autophagy and suppression of HSC activation (164).”
BackgroundZhou, T., Chang, L., Luo, Y., Zhou, Y., & Zhang, J. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101299 · Cited by 9 · cited 1×
“Studies have demonstrated that macrophage-stimulating protein 1 (Mst1) mediates mitochondrial autophagy by regulating Parkin expression through the AMPK pathway, which further promotes NAFLD (74).”
BackgroundCholangiocyte lipoapoptosis: Implications for biliary damage during nonalcoholic fatty liver disease
Martínez, A. K., & Glaser, S. S. (2014) · Hepatology · doi:10.1002/hep.27341 · Cited by 8
Ge, J., Li, H., Yang, J., Yue, Y., Lu, S., Nie, H., Zhang, T., Sun, P., Yan, H., Sun, H., et al. (2023) · Medicine · doi:10.1097/md.0000000000033698 · Cited by 5 · cited 1×
“…cells exhibit a contractile, proliferative, and fi brogenic phenotype, which can be further distinguished from quiescent hepatic stellate cells by the loss of their retinol-containing lipid droplets. in fl ammatory state of NAFLD by inhibiting M1 polarization and NLRP3 in fl ammasome activation (106).”
BackgroundĆirić, D., Kravić-Stevović, T., Bumbasirevic, V. Z., Petricevic, S. M., Jovanović, S., Trajković, V., & Martinović, T. (2022) · Ultrastructural Pathology · doi:10.1080/01913123.2022.2156639 · Cited by 4
[Macrophage heterogeneity role in NAFLD and NASH disease progression].
Yang, T., Wang, X., Jiang, L., & Li, J. (2023) · PubMed Central · doi:10.3760/cma.j.cn501113-20220428-00223 · Cited by 2 · cited 1×
“KCs, the liver-resident macrophages, originate from yolk sac progenitor cells and are integral to liver homeostasis, in fl ammation, and fi brosis regulation (98, 99).”
Background
Cited by
Giangregorio, F., Mosconi, E., Debellis, M. G., Provini, S., Esposito, C., Garolfi, M., Oraka, S., KALOUDI, O., Mustafazade, G., Marín‐Baselga, R., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13195880 · Cited by 79
“Fibrosis in MASLD can be categorized into stages F0 to F4, with F3 and F4 being considered advanced fibrosis [62].”
BackgroundEldken, Z. H., Youssef, O. M., Khalil, R. M., Kassab, A., Ramadan, A., & Sakr, N. H. (2025) · Scientific Reports · doi:10.1038/s41598-025-11135-2 · Cited by 7
“Although TNF-α is not pyroptosis-specific, its elevated expression and histological evidence indicate pyroptosis in MAFLD.”
InfluentialXie, W., Lv, Y., Zhou, Z., Wang, G., Zhang, X., Peng, D., Yang, H., Liao, J., Sun, X., Lin, W., et al. (2026) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-026-01177-9 · Cited by 6
“In the context of NAFLD, autophagy plays a critical role in regulating lipid metabolism and modulating inflammatory responses (Shen et al. 2024).”
InfluentialAutophagy as a therapeutic linchpin in metabolic diseases and obesity-associated diabetes
Vakili, O., Klionsky, D. J., Reiter, R. J., Ren, J., Deshpande, A., Ahn, K. S., Cho, W., Hushmandi, K., & Kumar, A. P. (2026) · Autophagy · doi:10.1080/15548627.2026.2636096 · Cited by 10
“…primarily of misfolded and crosslinked KRT8 (keratin 8) and KRT18, ubiquitinated proteins such as SQSTM1/p62, and other damaged proteins, which accumulate in damaged hepatocytes especially during alcoholic and nonalcoholic steatohe-patitis, as well as other liver metabolic defects [201–203].”
Pesticides Drive Liver Diseases Through Non-Apoptotic Regulated Cell Death Pathways
Khairullina, Z. S., Kurmangaliyeva, S. S., Yussupov, R., Kelimberdiyeva, E., Tryfonyuk, L., Shapambayev, N., Seidakhmetova, A., Medetbekov, T., & Tkachenko, A. (2026) · Diseases · doi:10.3390/diseases14030096 · Cited by 3
Metadata
- Authors
- Shen, Q., Yang, M., Wang, S., Chen, X., Chen, S., Zhang, R., Xiong, Z., & Leng, Y.
- Affiliations
- Changchun University of Chinese Medicine (CN)
- Corresponding author
- Leng, Yan
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2024-08-08
- Volume
- 15
- Pages
- 1374644-1374644
- ISSN
- 1664-2392 (ISSN-L)
- PMC
- PMC11338765
- OpenAlex
- W4401435151
- Cited by
- 15
- References
- 197
- Citations by year
- 2026: 9 · 2025: 5 · 2024: 1
- FWCI
- 0.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Endocrinology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Natural Science Foundation of Jilin Province
- People's Government of Jilin Province
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- non-alcoholic fatty liver disease, autophagy, hepatic stellate cells, liver fibrosis, hepatocytes, Kupffer cells, autophagy signaling, pro-inflammatory factors, NAFLD progression
- MeSH terms
- Animals, Autophagy, Humans, Kupffer Cells, Signal Transduction, Disease Progression, Hepatocytes, Hepatic Stellate Cells, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.